BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15713410)

  • 21. The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site.
    Harris SF; Shiau AK; Agard DA
    Structure; 2004 Jun; 12(6):1087-97. PubMed ID: 15274928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studies.
    Day JE; Sharp SY; Rowlands MG; Aherne W; Lewis W; Roe SM; Prodromou C; Pearl LH; Workman P; Moody CJ
    Chemistry; 2010 Sep; 16(34):10366-72. PubMed ID: 20661961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
    Dymock BW; Barril X; Brough PA; Cansfield JE; Massey A; McDonald E; Hubbard RE; Surgenor A; Roughley SD; Webb P; Workman P; Wright L; Drysdale MJ
    J Med Chem; 2005 Jun; 48(13):4212-5. PubMed ID: 15974572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.
    Sharp SY; Roe SM; Kazlauskas E; Cikotienė I; Workman P; Matulis D; Prodromou C
    PLoS One; 2012; 7(9):e44642. PubMed ID: 22984537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inside the Hsp90 inhibitors binding mode through induced fit docking.
    Lauria A; Ippolito M; Almerico AM
    J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Amino derivatives of the Hsp90 inhibitor CCT018159.
    Barril X; Beswick MC; Collier A; Drysdale MJ; Dymock BW; Fink A; Grant K; Howes R; Jordan AM; Massey A; Surgenor A; Wayne J; Workman P; Wright L
    Bioorg Med Chem Lett; 2006 May; 16(9):2543-8. PubMed ID: 16480864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
    Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
    J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.
    He H; Zatorska D; Kim J; Aguirre J; Llauger L; She Y; Wu N; Immormino RM; Gewirth DT; Chiosis G
    J Med Chem; 2006 Jan; 49(1):381-90. PubMed ID: 16392823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
    Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
    J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.
    Llauger L; He H; Kim J; Aguirre J; Rosen N; Peters U; Davies P; Chiosis G
    J Med Chem; 2005 Apr; 48(8):2892-905. PubMed ID: 15828828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors.
    Lauria A; Ippolito M; Almerico AM
    Comput Biol Chem; 2009 Oct; 33(5):386-90. PubMed ID: 19660987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsp90 inhibitors identified from a library of novobiocin analogues.
    Yu XM; Shen G; Neckers L; Blake H; Holzbeierlein J; Cronk B; Blagg BS
    J Am Chem Soc; 2005 Sep; 127(37):12778-9. PubMed ID: 16159253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.
    Murray CW; Carr MG; Callaghan O; Chessari G; Congreve M; Cowan S; Coyle JE; Downham R; Figueroa E; Frederickson M; Graham B; McMenamin R; O'Brien MA; Patel S; Phillips TR; Williams G; Woodhead AJ; Woolford AJ
    J Med Chem; 2010 Aug; 53(16):5942-55. PubMed ID: 20718493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational study on the interaction of N1 substituted pyrazole derivatives with B-raf kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site.
    Alzate-Morales JH; Vergara-Jaque A; Caballero J
    J Chem Inf Model; 2010 Jun; 50(6):1101-12. PubMed ID: 20524689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a novel Hsp90 inhibitor by fragment linking.
    Barker JJ; Barker O; Courtney SM; Gardiner M; Hesterkamp T; Ichihara O; Mather O; Montalbetti CA; Müller A; Varasi M; Whittaker M; Yarnold CJ
    ChemMedChem; 2010 Oct; 5(10):1697-700. PubMed ID: 20665758
    [No Abstract]   [Full Text] [Related]  

  • 39. Exploring the binding site of C-terminal hsp90 inhibitors.
    Sgobba M; Forestiero R; Degliesposti G; Rastelli G
    J Chem Inf Model; 2010 Sep; 50(9):1522-8. PubMed ID: 20828111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
    J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.